id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
987236,85fc0951-af88-415c-beaa-af7d171459cc,Q3,LONG TERM CARE PHARMACY ALLIANCE,400309443,LONG TERM CARE PHARMACY ALLIANCE,2010,third_quarter,PHA,Medicare Part D in Long Term Care,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,210000,0,0,2010-09-30T11:17:51.037000-04:00
987612,74dc0729-e70b-45af-b502-1ab7d013f9fc,Q3,MEREDITH MCGEHEE,79858,INTERNATIONAL AIDS VACCINE INITIATIVE,2010,third_quarter,PHA,Funding for programs to develop AIDS vaccines targeted toward the developing world; Working Global Health Technologies to educate on research and development programs aimed at the AIDS epidemic and other health issues; Implementation of PEPFAR Appropriations for USAID R&D and funding for IAVI; Providing information on IAVI's Antibody Project and PDP model; Providing input on foreign assistance reform from a global health perspective,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-04T12:14:36.837000-04:00
987927,2330c816-9c47-495a-bd8f-a641c3cc7bae,Q3,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,3457,AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS,2010,third_quarter,PHA,"Communications with Food and Drug Admnistration on Risk Evaluation and Mitigation Strategies, reauthorization of the Prescription Drug User Fee Act, medical product recalls, experimental study of patient information prototypes and patient medication information, drug shortages, and generic drug user fees.  Communication with Centers for Medicare and Medicaid Services regarding administration of medication to inpatients within 30 minutes of scheduled dosage time. HR 5389, The Medicare Clinical Pharmacist Practitioner Services Coverage Act of 2010, all provisions.","Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,250000,0,0,2010-10-05T15:34:29.837000-04:00
988241,8b0074fe-ecb9-494b-bcd0-04372dd21a2e,Q3,"THE OB-C GROUP, LLC",29802,ELI LILLY,2010,third_quarter,PHA,No specific bill number: matters relating to pharmaceutical manufacturers.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-06T13:37:05.427000-04:00
988357,6b3d7b2e-ef32-422c-9000-3dbb7f714c43,Q3,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2010,third_quarter,PHA,Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,64750,0,0,2010-10-06T15:52:22.300000-04:00
989075,cb0c4d0e-225e-4051-85db-9ea57a3916cf,Q3,GILBERT'S LLP,67876,MYLAN LABORATORIES INC,2010,third_quarter,PHA,Reform to legislation and regulations affecting pharmaceutical drug approval and marketing,,105000,,0,0,2010-10-08T13:58:58.820000-04:00
989578,4d857f80-8a16-4c50-8a7e-a8ec27ae407f,Q3,"CYBER SECURITY RESEARCH CONSULTANTS, LLC",91694,PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION,2010,third_quarter,PHA,"Food and Drug Safety Globalization Act
Monitoring Dorgan-Snowe Drug Reimportation from Canada
Health Care Reform","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2010-10-11T11:09:57.993000-04:00
989707,1b8f8e4e-d27b-47f7-888c-bae6da9aadb0,Q3,LOCKE LORD PUBLIC POLICY GROUP LLC,300971,MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES,2010,third_quarter,PHA,Pharmaceutical performance reimbursement; biogenics,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-11T15:24:51.677000-04:00
989742,6a344eb2-b00c-4278-bbc1-4f0c241bb325,Q3,INDEPENDENT PHARMACY COOPERATIVE,313098,INDEPENDENT PHARMACY COOPERATIVE,2010,third_quarter,PHA,"Average Manufacturer Price Pharmacy Reimbursement H.R. 3590 agency implementation
DEA Physician/Agent Definition in Skilled Nursing Facilities
PBM Transparency in Health Insurance ""Exchanges"" H.R. 3590
H.R. 3790 Repeals DMEPOS Competitive Bidding Medicare Centers For Medicare & Medicaid Services: Concerns with short-cycle dispensing in long-term care facilties.
IRS:Concerns with 1099 reporting provisions in PL 111-148.","Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE",,10000,0,0,2010-10-11T16:30:04.587000-04:00
989758,0027a4bd-0fc4-42b2-a23c-9fc2a28de7d2,Q3,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2010,third_quarter,PHA,"Increased appropriations for systems to shorten the time between development of a drug and its release to the public.
FDA reform as it relates to drug development and research
Collaborative research on drug development                                 anti-malarial pharmaceuticals
FY 2010 Agricultural Appropriations                                             human factors research related to neuropharmaceuticals","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)",,110000,0,0,2010-10-11T16:35:15.390000-04:00
989958,d64263d2-40b8-4bf5-a436-c598d5cd8bd0,Q3,HOLLAND & KNIGHT LLP,18466,AMERICAN SOCIETY OF HEMATOLOGY,2010,third_quarter,PHA,Hematology and Oncology drug research and approval issues.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2010-10-12T10:25:16.497000-04:00
989988,4473a560-f06b-46ac-80f3-9ebbf50ab45c,Q3,HOLLAND & KNIGHT LLP,18466,NATIONAL HEMOPHILIA FOUNDATION,2010,third_quarter,PHA,"Blood and blood product safety; issues related to blood product approvals; Blood donor deferral policies, 340B Drug purchasing program and orphan drugs.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",40000,,0,0,2010-10-12T10:34:19.177000-04:00
990140,56e75c33-746d-462c-87ff-c2c21f6a86a0,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2010,third_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.   No specific legislation has been introduced yet.

H.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps.  Amends the Controlled Substances Act to revise the definition of ""dispense"" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-10-12T12:14:54.020000-04:00
990229,83989e62-b43b-4a56-8c5b-62ba25464aa0,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2010,third_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-10-12T12:53:15.847000-04:00
990240,2e4009f0-23b1-4989-b9a4-a5bd119f9e41,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2010,third_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.

H.R. 3018 and S. 3274, To amend the Controlled Substances Act to address the use of intrathecal pumps.  Amends the Controlled Substances Act to revise the definition of ""dispense"" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-10-12T13:07:17.187000-04:00
990268,c9b098b0-6c17-4099-b847-c39c4f5ad0c7,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2010,third_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.

H.R. 3018 and S. 3274, To amend the Controlled Substances Act to address the use of intrathecal pumps.  Amends the Controlled Substances Act to revise the definition of ""dispense"" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-10-12T13:18:30.287000-04:00
990344,1ab2ac1e-a09b-48b5-a273-c4d171d0bae9,Q3,"PARRY, ROMANI, DECONCINI & SYMMS",30792,DIAMONDBACK DRUGS,2010,third_quarter,PHA,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.   No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation has been introduced yet.

H.R. 3018 and S. 3274, To amend the Controlled Substances Act to address the use of intrathecal pumps.  Amends the Controlled Substances Act to revise the definition of ""dispense"" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice.","HOUSE OF REPRESENTATIVES,SENATE",6000,,0,0,2010-10-12T14:13:03.877000-04:00
990749,b74f7f1f-8c73-4e56-9ccd-a03761c77c53,Q3,"RUBICON ADVISORS, LLC",315091,"BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.",2010,third_quarter,PHA,"Physiciam Payment Sunshine Act S 2029
Patent Settlements H.R. 14328 .316
Affordable Healthcare Choices Act",,30000,,0,0,2010-10-12T22:58:03.633000-04:00
990750,4e1ef1ff-f87d-48a2-83ca-7bf44abbd762,Q3,"RUBICON ADVISORS, LLC",315091,GILEAD SCIENCES,2010,third_quarter,PHA,"H.R. 822, H.R. 1943, H.R. 6114, S-2969",,75000,,0,0,2010-10-12T23:03:04.543000-04:00
990751,764fb4cb-b125-4270-937a-eae38aeab584,Q3,"RUBICON ADVISORS, LLC",315091,INSMED INCORPORATED,2010,third_quarter,PHA,"Generic Biologics S. 1695
Affordable Health Care Choices Act",,22500,,0,0,2010-10-12T23:08:05.453000-04:00
990752,d1f368c9-b4a8-47a7-8743-09c9ded1e2c0,Q3,"RUBICON ADVISORS, LLC",315091,OSMOTICA PHARMACEUTICALS,2010,third_quarter,PHA,"FDA Citizen Petition Reform
Affordable Healthcare Choices Act",,35000,,0,0,2010-10-12T23:15:06.383000-04:00
990753,b3c0dda7-17fa-47a6-927d-bb15b4a08337,Q3,"RUBICON ADVISORS, LLC",315091,TEVA PHARMACEUTICALS USA,2010,third_quarter,PHA,"Patent Settlements H.R. 1432, Genetic Biologics  S. H.R. 1695, H.R. 5629, Physician Payment Sunshine Act S 2029, Patent Reform H.R.  1908, Import Safety Act H.R. 3100
Affordable Health Choices Act",,105000,,0,0,2010-10-12T23:19:07.290000-04:00
990754,a918e9af-a8f0-4324-9919-93625bcb127e,Q3,"RUBICON ADVISORS, LLC",315091,WATSON PHARMACEUTICALS INC,2010,third_quarter,PHA,"Patent Reform H.R. 1908, Import Safety Act H.R. 2100             Affordable Health Choices Act
Patent Settlements H.R. 1432 S. 316
Generic Biologics S. 1685 H.R. 5629
Physician Payment Sunshine Act S. 2029",,98000,,0,0,2010-10-12T23:23:08.217000-04:00
991258,494026f5-5cb6-4166-b267-2d50522616ff,Q3,RANDOLPH E. CLOUD & ASSOCIATES,400451152,PHRMA(ON BEHALF OF WE WORK FOR HEALTH),2010,third_quarter,PHA,"Issues dealing with pharmaceutical innovation, patent protection, and Medicaid reimbursement duringly being implemented or discussed in Congress PhRMA Members found here:

http://www.phrma.org/about_phrma/member_company_list/members","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2010-10-13T12:56:20.037000-04:00
991542,b08c1dde-f2c8-4181-be30-955f3e6dd2fb,Q3,ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,58534,ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM,2010,third_quarter,PHA,"S3686
Support language that amends section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers, by expanding 340 B drug discounts to inpatient settings.","HOUSE OF REPRESENTATIVES,SENATE",,80530,0,0,2010-10-13T14:48:26.493000-04:00
991580,2aff2717-5515-443d-9850-78604c031d9e,Q3,"NAHIGIAN STRATEGIES, LLC",322897,TEVA PHARMACEUTICALS USA INC,2010,third_quarter,PHA,Generic pharmaceuticals issues.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-10-13T15:00:37.110000-04:00
991646,f04527c4-55d2-45be-9dd6-8e8e171982aa,Q3,"OMNICARE, INC.",321112,OMNICARE INC,2010,third_quarter,PHA,DEA policies regarding dispensing of controlled substances to residents of long-term care facilities.,"HOUSE OF REPRESENTATIVES,SENATE",,90000,0,0,2010-10-13T15:30:13.377000-04:00
992361,3faece46-88d3-48d8-86df-2d1aa9b583dd,Q3,"DUTKO WORLDWIDE, LLC",12868,NEWAYS INTERNATIONAL,2010,third_quarter,PHA,"Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (S. 510).
Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796).","Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-14T10:43:04.687000-04:00
992937,b59f2833-d6f7-4bb1-a9bb-5cc425f4e0cc,Q3,HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA),28776,HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA),2010,third_quarter,PHA,"Importation of prescription drugs (S. 525/H.R. 1298); House Energy and Commerce Committee discussion draft; Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923); Pharmacy Benefit Management (PBM) issues (H.R. 4489); Drug Disposal (S. 3397, H.R. 5809); PDMP Funding/NASPER Reauthorization (H.R. 5710)","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,270000,0,0,2010-10-14T13:30:16.567000-04:00
993886,606afef9-7e70-412a-aea8-361d68a47b84,Q3,CAPITOL HILL CONSULTING GROUP,72053,PURDUE PHARMA LLP,2010,third_quarter,PHA,Controlled Drug Substances Act (21 USC 13),"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-14T18:45:57.673000-04:00
993936,61e4d787-7b44-4787-afbd-18f617b2d948,Q3,WINBORN SOLUTIONS LLC,308310,PERRIGO CO,2010,third_quarter,PHA,"Dextromethorphan Distribution Act of 2009
Legislation to regulate the sale of pseudoephedrine
Food and drug safety, user fee, and country of origin legislation","HOUSE OF REPRESENTATIVES,SENATE",18000,,0,0,2010-10-14T20:18:23.780000-04:00
994240,a1a2ecdb-fce0-4862-aec6-2020cfdd7d11,Q3,AMERICAN ADVERTISING FEDERATION,1411,AMERICAN ADVERTISING FEDERATION,2010,third_quarter,PHA,"health care reform legislation as it affects the taxation or content of pharmaceutical advertising
HR 2175, to prohibit as indecent the broadcasting of any advertisement for a medication for the treatment of erectile dysfunction
Proposals to require a moratorium on the advertising of new prescription medications
Proposals to extend Food and Drug Administration authority for over-the-counter medications","Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2010-10-15T11:21:00.357000-04:00
994296,acdeee71-475f-4457-a9be-e449b74905e4,Q3,INDEPENDENCE BLUE CROSS,19172,INDEPENDENCE BLUE CROSS,2010,third_quarter,PHA,"comparative effectiveness, medication safety

pharmacy antitrust issues??","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,White House Office",,,0,0,2010-10-15T11:37:39.353000-04:00
994539,c41c4e14-4dda-4666-8c73-7f37218e9c9c,Q3,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION,31348,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION,2010,third_quarter,PHA,"H.R. 1204 - Community Pharmacy Fairness Act, Electronic Prescribing, Mail Order and Pharmacy Chronic Care Management
H.R. 1706, S369 relating to settlement payments between brand and generic manufacturers, issues related to oversight of pharmacy benefits for federal employee health benefits program, items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in H.R. 3200, S11679 America's Health Future Act, issues related to generic dispensing and study of the impact of state 'carve-out"" laws on generic utilization.
H.R. 4199 - Patients Health and Real Medication Access Cost Savings Act.
H.R. 5234 - PBM Audit Reform and Transparency Act
H.R. 4872 - Health Care and Education and Reconciliation Act of 2010
H.R. 4813 - To provide for insurance reform (including health insurance reform) amend Title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.
H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
H.R. 3950 - Patient Protection and Affordable Care Act","Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Election Commission (FEC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,644765,0,0,2010-10-15T13:00:00.737000-04:00
996244,fcc46331-4891-455e-8011-34569890b5d1,Q3,BLUE CROSS BLUE SHIELD OF MICHIGAN,46676,BLUE CROSS BLUE SHIELD OF MICHIGAN,2010,third_quarter,PHA,"Comparative Effectiveness

Pharmacy Anti-Trust","HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2010-10-18T09:08:24.870000-04:00
996590,3650c7a9-a845-4ff5-84b9-0263264781b2,Q3,UNIVERSITY OF CONNECTICUT,39382,UNIVERSITY OF CONNECTICUT,2010,third_quarter,PHA,"S.3606, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA salaries and expenses; and extramural research related issues.","Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA)",,70000,0,0,2010-10-18T10:35:13.793000-04:00
996620,c7a4333b-affa-4725-8203-7b7a2424ad20,Q3,POLICY DIRECTIONS INC.,31747,ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ),2010,third_quarter,PHA,"Antibiotics in animal foods
Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine.

S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA.

Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling.

Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act.

Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds.","Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-18T10:38:22.403000-04:00
997045,e1717dc3-9c22-4305-9b8c-37bfb7792e44,Q3,BROWN RUDNICK LLP,287895,HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC,2010,third_quarter,PHA,"S.525 & S.1298- Pharmaceutical Market Access and Drug Safety Act of 2009; Drug Pedigree
House Energy and Commerce Committee Drug Import Safety Discussion Draft","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2010-10-18T11:31:50.090000-04:00
997130,d68e62e4-8eb4-4677-b248-cabe4f388e27,Q3,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,27478,NATIONAL COMMUNITY PHARMACISTS ASSOCIATION,2010,third_quarter,PHA,"H.R. 1204, the Community Pharmacy Fairness Act of 2009; H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2010 and working on Senate companion; H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 and working on Senate companion; working with Senate Committee on Health, Education, Labor and pensions on a potential hearing; working with House Committee on Energy and Commerce (health subcommittee) on a potential hearing; worked with the Senate Committee on Aging to provide information for an ongoing committee investigation of certain retail pharmacy practices; H.R. 5235, the Medicare Access to Diabetes Supplies Act of 2010 and working on Senate companion; H.R. 3790, legislation to eliminate the Medicare Part B DME competitive bidding program; submitted statement for the House Committee on Energy and Commerce hearing on the Part B DME competitive bidding program; H.R. 1586, the Education Jobs and Medicaid funding bill, which included an extension of FMAP and change to the AMP definition and became law on 8/10/2010; H.R. 5136 and S. 3454, the FY11 National Defense Authorization Act, includes funding for the Department of Defense and covers the TRICARE pharmacy program; H.R. 3108 and S. 1383, the Medication Therapy Management (MTM) Expanded Benefit Act; worked with Senate offices to gain support for the implemenation of an authpirzed grant program for MTM services; worked with Senate Aging Committee on the issue of nurses as agents in long-term care facilties; H.R. 5710, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 (NASPER); H.R. 5809, the Safe Drug Disposal Act and S. 3397, the Secure & Responsible Drug Disposal Act (became law 10-12-10); worked with Congressional offices on the issue of Medicare Part B recoupment by CMS; sough Congressional support for the FTC investigation of the merger between a major retail pharmacy chain and a national pharmacy benefit manager (PBM); worked with Congressional offices in seeking clarification from the Department of Treasury regarding the new ""over the counter"" rules with Flexible Spending Accounts (FSA).","Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,Small Business Administration (SBA),Treasury, Dept of",,130000,0,0,2010-10-18T11:43:38.637000-04:00
997141,299a11b0-4a6e-4077-988d-7544ee873734,Q3,"MEHLMAN CONSULTING, INC.",284950,ABBOTT LABORATORIES,2010,third_quarter,PHA,"Drug pricing, FDA reforms, Reimbursement.","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2010-10-18T11:46:46.107000-04:00
997768,c26fed67-88cc-4ac4-8ea2-36a4f281bd4d,Q3,ELI LILLY AND COMPANY,13392,ELI LILLY AND COMPANY,2010,third_quarter,PHA,Hospital discounts (HR 3590),"Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)",,2135000,0,0,2010-10-18T13:51:10.507000-04:00
997971,3eabaea5-c76a-4fff-b13a-70a59e1e2e76,Q3,GREATER NEW YORK HOSPITAL ASSOCIATION,16830,GREATER NEW YORK HOSPITAL ASSOCIATION,2010,third_quarter,PHA,"Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers (various health care reform proposals (including the American Health Care Choices Act (S.1679); H.R.3962; H.R.3590, P.L. 111-148; H.R.4872, P.L. 111-152); 340B Program Improvement and Integrity Act of 2009 (H.R. 444/S.1239); H.R.4213)","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,300000,0,0,2010-10-18T14:24:23.280000-04:00
998051,7f177fcc-406b-4eb9-801f-f21b37cf4bfa,Q3,JULIE PHILP,400407928,NATIONAL GRASSROOTS AND COMMUNICATION,2010,third_quarter,PHA,Support legislation (HR 4199) to define pharmacists as health care providers under Medicare; increase dispensing fees for pharmacies; eliminate spread pricing; return rebates to health care plans; and create a fund to pay for prescription medicines for low-income indidviduals.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-18T14:37:44.030000-04:00
998174,7362913f-3934-4fec-abef-98c71840e89f,Q3,THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK,309377,ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK,2010,third_quarter,PHA,Support legislation (HR4199) to define pharmacists as health care professionals under Medicare; increase dispensing fees for pharmacies; elimiate spread pricing; return rebates to health care plans; and create a fund for prescription medicines for low-income individuals.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-10-18T14:49:15.043000-04:00
998302,1ce73ca7-00cc-46e1-900d-3abaa477a94b,Q3,FAEGRE BAKER DANIELS CONSULTING,34158,ELI LILLY,2010,third_quarter,PHA,issue is on-line pharmacies,"Executive Office of the President (EOP),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE",8000,,0,0,2010-10-18T15:03:54.257000-04:00
998534,334dc5c6-2d66-459b-a472-dcd7fd08d97f,Q3,SMITH GARSON FKA SMITH DAWSON & ANDREWS,35707,PROSETTA CORPORATION,2010,third_quarter,PHA,Government Advertisement of Biopharmaceuticals,SENATE,7500,,0,0,2010-10-18T15:34:52.743000-04:00
998584,57f3b73d-618f-4443-9edc-14fb0ee2280d,Q3,SMITH GARSON FKA SMITH DAWSON & ANDREWS,35707,STRUVE SWINE TECHNOLOGIES,2010,third_quarter,PHA,Government Advertisement of Biopharmaceuticals,SENATE,7500,,0,0,2010-10-18T15:42:13.117000-04:00
998641,90414ef6-33b2-4e52-8631-fb9607da8849,Q3,VENABLE LLP,39941,ENDO PHARMACEUTICALS INC,2010,third_quarter,PHA,General issues affecting the pharmaceutical industry,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2010-10-18T15:47:49.530000-04:00
998657,ad32ce91-6c3a-4edc-8b5d-10c756776692,Q3,"PD FRAZER CONSULTING, INC.",65998,CANADA INTERNATIONAL PHARMACY ASSOCIATION,2010,third_quarter,PHA,Monitor the development of proposed bills about the importation of prescription drugs.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-18T15:51:47.773000-04:00
998792,3a599f70-348c-466b-9f97-d053195dde95,Q3,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",4653,"ASSOCIATION OF NATIONAL ADVERTISERS, INC.",2010,third_quarter,PHA,"Proposals to place a moratorium on prescription drug advertising and requiring a ""fair balance"" between risk and benefit information in prescription drug advertisements
Proposals to extend FDA authority to over-the-counter drug advertisements
FDA notice of proposed rulemaking to implement requirements for ""major statement"" in DTC television or radio ads H.R. 2175 - Families for ED Decency Act, to prohibit the broadcast of drugs for erectile dysfuncton/male enhancement on indecency grounds","Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,270000,0,0,2010-10-18T16:12:47.373000-04:00
998877,b33de76b-8c88-497f-b66d-e31fcc139495,Q3,SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES,37538,SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES,2010,third_quarter,PHA,"HR 4816, the Food and Drug Administration Improvement Act of 2010, provisions related to providing the Food and Drug Administration with resources to ensure safety of drugs imported into the US from foreign countries.
S. 3690  Drug Safety and Accountability Act of 2010, provisions related to provising the Food and Drug Administration with adequate resources to ensure safety of drugs imported to the US from foreign manufacturers.","HOUSE OF REPRESENTATIVES,SENATE",,79000,0,0,2010-10-18T16:25:16.090000-04:00
999533,0509b863-295e-4f1b-9a8a-386e9fa02063,Q3,"PODESTA GROUP, INC.",31680,COVIDIEN,2010,third_quarter,PHA,"Issues involving controlled substances and pain and addiction drugs generally
Issues related to acetaminophen","Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE",50000,,0,0,2010-10-18T18:47:22.793000-04:00
999555,4bb57868-9464-4507-bcfa-0be31f2bd8a9,Q3,"PODESTA GROUP, INC.",31680,MILLENNIUM PHARMACEUTICALS INC,2010,third_quarter,PHA,"Drug Safety/Pedigree Bills
P.L. 111-148 Patient Protection and Affordable Care Act
P.L. 111-152 Health Care and Education Reconciliation Act of 2010","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-10-18T18:52:36.060000-04:00
1001052,d68a9ba6-3c70-48cc-aadd-022a3d3ac542,Q3,AMYLIN PHARMACEUTICALS,308536,AMYLIN PHARMACEUTICALS,2010,third_quarter,PHA,Drug importation issues,"HOUSE OF REPRESENTATIVES,SENATE",,200000,0,0,2010-10-19T10:22:49.397000-04:00
1001433,65da2f63-b859-4ce3-b900-e77bcb08476a,Q3,"TARPLIN, DOWNS & YOUNG, LLC",304736,ASTRAZENECA,2010,third_quarter,PHA,"**see addendum page **, no specific bill(s), Prescription Drug Importation, Import Safety

Import Safety
     H.R. 759  Food and Drug Administration Globalization Act of 2009
     S. 510  FDA Food Safety Modernization Act

Importation
     S. 525/H.R. 1298  Pharmaceutical Market Access and Drug Safety Act of 2009
     S. 80  Pharmaceutical Market Access Act of 2009","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-10-19T10:58:05.333000-04:00
1001508,39df83fc-3332-4d1a-b1e4-cd52f22a4d68,Q3,"GREENBERG TRAURIG, LLP",16896,"RICHIE & GUERINGER, P.C.",2010,third_quarter,PHA,Congressional actions on health care reform.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-10-19T11:01:28.833000-04:00
1001891,a3cc888c-d903-497d-86d6-72c4f9dd0efe,Q3,"KENT & O'CONNOR, INC.",21426,INTERNATIONAL WAREHOUSE LOGISTICS ASSOCIATION,2010,third_quarter,PHA,Legislation and regulations relating to drug safety issues,"Consumer Product Safety Commission (CPSC),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Labor Relations Board (NLRB),SENATE,Surface Transportation Board (STB),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Customs & Border Protection",20000,,0,0,2010-10-19T11:24:16.643000-04:00
1001919,1eaa3364-5b4d-4347-9dc2-05a94414ebbb,Q3,OGR,48827,SANOFI PASTEUR,2010,third_quarter,PHA,vaccine related issues,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-10-19T11:26:28.847000-04:00
1002056,988ef3fe-d500-422e-bcdd-795bd8bc184c,Q3,"VAN HEUVELEN STRATEGIES, LLC",321874,DAVITA,2010,third_quarter,PHA,"H.R. 1, American Recovery and Reinvestment Act of 2009; Provisions pertaining to kidney care, dialysis, Medicare, CMS reimbursement issues,and health insurance; S.Con.Res. 13 - FY 2010 Budget; S. 1679, The Affordable Health Choices Act; H.R. 3200, America's Affordable Health Choices Act of 2009; S. 1796, America's Healthy Future Act; S. 1776, Medicare Physician Fairness Act","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-19T11:34:58.413000-04:00
1002154,89648d3f-ff6f-4ae9-9a45-3d11e6325da2,Q3,THE CHILDREN'S HOSPITAL OF PHILADELPHIA,9077,THE CHILDREN'S HOSPITAL OF PHILADELPHIA,2010,third_quarter,PHA,"H.R. 4213, the ""American Workers, State and Business Relief Act of 2010,"" Title V, Subtitle B, Section 517 relation to the inclusion of ophan drugs under the 340B drug discount program for eligbile children's hospitals","Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,45000,0,0,2010-10-19T11:46:01.987000-04:00
1002324,61481c99-f153-483e-bec7-967ba17dabd7,Q3,AMERICAN VETERINARY MEDICAL ASSOCIATION,3630,AMERICAN VETERINARY MEDICAL ASSOCIATION,2010,third_quarter,PHA,"H.R. 1549/S. 619, Preservation of Antibiotics for Medical Treatment Act
H.R. 2400, Strategies to Address Antimicrobial Resistance (STAAR) Act
Potential veterinary prescription writing legislation","Agriculture, Dept of (USDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,120000,0,0,2010-10-19T11:59:05.380000-04:00
1002354,fe183bcc-7d78-4de4-a661-bbe6932d39a7,Q3,"R AND J GROUP, INC.",400483384,SUNOVIAN PHARMACEUTICALS INC (F/K/A SEPRACOR INC ),2010,third_quarter,PHA,Legislation affecting the pharmaceutical industry; healthcare reform bill.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-19T12:02:04.517000-04:00
1002460,257d611e-204f-4370-9aad-37d87f35538f,Q3,"TARPLIN, DOWNS & YOUNG, LLC",304736,HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.),2010,third_quarter,PHA,"**see addendum page Importation of prescription drugs (S.525/H.R. 1298)
RX Pedigree
Import Safety (H.R. 759)
Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923))
Pharmacy Benefit Management Issues (H.R. 4489)
Drug Disposal (S. 3397, H.R. 5809)
PDMP Funding/NASPER reauthorization (H.R. 5710)","Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2010-10-19T12:09:46.490000-04:00
1002573,3aebde46-0d8e-403f-a78b-455ee2eb8f7c,Q3,340B HEALTH,316434,340B HEALTH,2010,third_quarter,PHA,S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity.  Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,241325,0,0,2010-10-19T12:17:16.953000-04:00
1003093,48b07e60-b190-4d29-9daf-c3cbce9cfb97,Q3,"EXPRESS SCRIPTS, INC.",294416,"EXPRESS SCRIPTS, INC.",2010,third_quarter,PHA,"Items related to reverse settlement payments between manufacturers--HR 1706, S 369
Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489
Design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements--HR 3590, HR 4872 Policies related to restricting PBMs' ability to manage prescription drug benefits -- HR 4199 HR 5234, PBM Audit Reform and Transparency Act","Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,430000,0,0,2010-10-19T13:00:12.460000-04:00
1003103,e93c0fb1-28bf-4700-9d27-60ca1af08d36,Q3,"FLYNN & ASSOCIATES, INC.",15020,PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION,2010,third_quarter,PHA,Pharmaceutical Industry Employment Issues,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2010-10-19T13:04:15.460000-04:00
1004087,cefdcb28-ac02-43a7-9dd7-6f4de41d9009,Q3,EISAI INC.,400321512,EISAI INC.,2010,third_quarter,PHA,"biosimilars, follow-on biologics
Biologics Price Competition and Innovation Act of 2009
P.L. 111-148 Patient Protection and Affordable Care Act
P.L. 111-152 health Care and Education Reconciliation Act of 2010","Education, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE",,800000,0,0,2010-10-19T14:30:12.943000-04:00
1004165,b73c0427-f154-4ff2-9034-a2d1b5da009b,Q3,HANCE SCARBOROUGH,17443,INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION),2010,third_quarter,PHA,Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-10-19T14:34:13.267000-04:00
1004434,4600bcca-e49b-4132-9855-dec2f393bedb,Q3,HANCE SCARBOROUGH,17443,TEXAS ACADEMY OF COMPOUNDING PHARMACISTS,2010,third_quarter,PHA,Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-10-19T14:49:53.877000-04:00
1004437,d2809579-c79b-4de6-9701-3939eb51f7aa,Q3,MCDERMOTT WILL & SCHULTE LLP,24338,"ALLERGAN, INC.",2010,third_quarter,PHA,Issues related to Section 340B of the Public Health Service Act.,"Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-10-19T14:49:55.877000-04:00
1004604,f1a4e68d-f766-4df9-adac-38402db65ee4,Q3,AMERICAN PHARMACISTS ASSOCIATION,3071,AMERICAN PHARMACISTS ASSOCIATION,2010,third_quarter,PHA,"HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010
S 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2009
S 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 
S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009
HAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program
HR 1204 - The Community Pharmacy Fairness Act of 2009
S 754 - The Methadone Treatment and Protection Act of 2009 
HR 2855 - The Drug Overdose Reduction Act
HR 163 - Prescription Drug Affordability Act
HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps

(Docket Number: FDA2010N0184) Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Patient Information Prototypes
(Docket Number: FDA2010N0001) Joint Meeting of the Anesthetic and Life Support Drugs Advisory
Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting on Opioid REMS
(Docket Number: FDA2010N0168) Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Request for Comments
(Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings
(Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period
(Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing
(Docket Number: DEA  337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information
(Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies

DEA National Drug Take-Back Day 

Concept  Standardizing REMS programs, components and development of a potential tiered REMS System","Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)",,212859,0,0,2010-10-19T14:57:56.533000-04:00
1005039,00ce4b06-be71-45b2-8f7f-07e1934e0de3,Q3,AKIN GUMP STRAUSS HAUER & FELD,682,"PRASCO, INC.",2010,third_quarter,PHA,Promoting consumer benefits of authorized generic drugs,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-19T15:20:37.177000-04:00
1005062,f52e54a3-d453-4673-86bb-47cb6e3d658f,Q3,ASSOCIATION FOR ACCESSIBLE MEDICINES,16032,ASSOCIATION FOR ACCESSIBLE MEDICINES,2010,third_quarter,PHA,"Budget Reconcilliation, Implementation of Health Care Reform, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs S.501 - Fair Prescription Drug Competition Act, all provisions
S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II
H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II
S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009
H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies
H.R.4872 - Reconciliation Bill, Section 1101, Closing the Medicare Prescription Drug ""Donut Hole""
H.R.4213 - American Jobs and Closing Tax Loopholes Act
H.R.4899 - War Supplemental
S.1315 - Drug Price Competition Act of 2009","Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR),White House Office",,372750,0,0,2010-10-19T15:21:45.410000-04:00
1005446,16c45f45-01ba-4098-9e37-7ee3a315cd00,Q3,AMERICAN HEALTH CARE ASSOCIATION,2491,AMERICAN HEALTH CARE ASSOCIATION,2010,third_quarter,PHA,"Updating controlled sustances regulations for long-term care. 
 S.3397: Secure and Responsible Drug Disposal Act of 2010. 
H.R.5809: The Safe Drug Disposal Act of 2010.","Bureau of Citizenship & Immigration Services (BCIS),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Labor, Dept of (DOL),SENATE",,500000,0,0,2010-10-19T15:41:21.427000-04:00
1005522,52fd765b-208e-4684-818b-c9b042d1a4c7,Q3,FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC),86196,PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA),2010,third_quarter,PHA,Monitor legislative developments in health care,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2010-10-19T15:45:10.287000-04:00
1005767,c9553b01-64fd-4259-a6d2-5628e4fb32fd,Q3,FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC),86196,THE PEW CHARITABLE TRUSTS,2010,third_quarter,PHA,Issues pertaining to pharmaceutical supply chain and drug safety.,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-10-19T15:56:27.677000-04:00
1005849,0d35179f-f1d3-4135-8c8a-e60ad6883ffc,Q3,INTEGRATED SOLUTIONS GROUP,317275,TEVA PHARMACEUTICALS USA,2010,third_quarter,PHA,"H.R. 1432 - Patent Settlements; H.R. 1695 - Generic Biologics; H.R. 5629 - Physician Payment Sunshine Act;
S.2029 - Patent Reform; H.R. 1908 - Import Safety Act; H.R. 3100 - Affordable Health Choices Act
S.515 - Patent Reform Act
Financial services and general appropriations bill - 2010","Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-10-19T16:02:24.927000-04:00
1005888,15056c92-ba6e-4582-bef6-d4390fa19c2d,Q3,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,26672,NATIONAL ASSOCIATION OF CHAIN DRUG STORES,2010,third_quarter,PHA,"H.R.3590, Patient Protection and Affordable Care Act
H.R.4872, Reconciliation Act of 2010
H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. S.525, Pharmaceutical Market Access Act
S.1232, Pharmaceutical Market Access and Drug Safety Act
H.R.1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations.
H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program.
H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program.
H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs.
S.256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine.
S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements.
H.R.2221, Data Accountability and Trust Act, as related to provider privacy requirements.
H.R.4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP.
S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds.
S.3543, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010.
H.R.5136, National Defense Authorization Act for Fiscal Year 2011.
S.3454, National Defense Authorization Act for Fiscal Year 2011.
H.R.5235, Medicare Access to Diabetes Supplies Act.
S.80, Pharmaceutical Market ccess Act of 2009.
S.511, Access to Durable Medical Equipment Act
S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,400000,0,0,2010-10-19T16:06:18.757000-04:00
1006089,2d37b22e-7b17-4ecf-b43b-83ef123bc9bf,Q3,MCDERMOTT WILL & SCHULTE LLP,24338,RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION,2010,third_quarter,PHA,Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444.,"Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE",80000,,0,0,2010-10-19T16:17:04.690000-04:00
1006175,694335b4-a335-419d-b663-4efd5aa70f27,Q3,BUCHANAN INGERSOLL & ROONEY PC,55291,GENERIC ANIMAL DRUG ALLIANCE,2010,third_quarter,PHA,Legislative issues relating to United States Food & Drug Administration.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-10-19T16:21:27.690000-04:00
1006426,e46b3d41-9a2d-450d-b1e9-21ffc215f0cf,Q3,"TARPLIN, DOWNS & YOUNG, LLC",304736,BIOTECHNOLOGY INDUSTRY ORGANIZATION,2010,third_quarter,PHA,"**see addendum page Import Safety
     H.R. 759  Food and Drug Administration Globalization Act of 2009
     S. 510 - FDA Food Safety Modernization Act

Importation
     S. 525/H.R. 1298  Pharmaceutical Market Access and Drug Safety Act of 2009
     S. 80  Pharmaceutical Market Access Act of 2009

     
***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety","HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2010-10-19T16:38:59.980000-04:00
1006668,32c4b0db-9069-4656-936f-1a1ee2e82a8b,Q3,TARPLIN STRATEGIES LLC,40032282,"GENENTECH, INC.",2010,third_quarter,PHA,"Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program, structure of the Medicare prescription drug benefit.
H.R. 4213, the American Jobs, Closing Tax Loopholes and Preventing Outsourcing Act of 2010 - eligibility changes related to the 340B program, treatment of certain drugs for computation of Average Manufacturer's Price under the Medicaid program. Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid reimbursement, fees assessed on the pharmaceutical industry, design and structure of the Medicare prescription drug benefit.","Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",75000,,0,0,2010-10-19T16:54:17.637000-04:00
1006673,c3f2e2af-7c53-4c7f-bfcc-4ce3caed019c,Q3,"TARPLIN, DOWNS & YOUNG, LLC",304736,PHRMA,2010,third_quarter,PHA,"**see addendum page Import Safety
     H.R. 759  Food and Drug Administration Globalization Act of 2009
     S. 510  FDA Food Safety Modernization Act

Importation
     S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009
     S. 80 - Pharmaceutical Market Access Act of 2009


***, no specific bill(s), prescription drug importation, import safety","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2010-10-19T16:54:20.137000-04:00
1006860,e902bf11-02a1-48d4-a600-9b8bbcce8f25,Q3,"WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC",41113,"JARROW FORMULAS, INC.",2010,third_quarter,PHA,"Federal food safety legislation affecting dietary supplements, and concerning Codex Alimentarius;  S. 510 and the Dietary Supplement Health and Education Act","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-19T17:10:41.127000-04:00
1006972,da708c83-e61e-43d9-b2de-ccb53eee25d4,Q3,MCDERMOTT WILL & SCHULTE LLP,24338,ISIS PHARMACEUTICALS,2010,third_quarter,PHA,"Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.","HOUSE OF REPRESENTATIVES,SENATE",75000,,0,0,2010-10-19T17:23:25.097000-04:00
1007086,00247839-36cc-4722-ae60-7b947abe9afd,Q3,KAISER FOUNDATION HEALTH PLAN INC.,21027,KAISER FOUNDATION HEALTH PLAN INC,2010,third_quarter,PHA,"S 726 Promoting Innovation and Access to Life-Saving Medicine Act
To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other products.
Sponsor: Schumer (D-NY)","Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,180000,0,0,2010-10-19T17:31:02.267000-04:00
1007276,05d32b39-baf7-4c9b-98ac-b402beed57c0,3T,FABIANI & COMPANY,72576,AFRAXIS,2010,third_quarter,PHA,Securing federal R&D for treatment of central nervous system diseases,"Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),Natl Institutes of Health (NIH),SENATE",,,0,1,2010-10-19T17:45:36.650000-04:00
1007383,863b844b-3f5d-4452-9c2d-1f77d0c90a34,Q3,"PODESTA GROUP, INC.",31680,NOVO NORDISK INC,2010,third_quarter,PHA,"Drug Importation, Biosimilars
P.L. 111-148 Patient Protection and Affordable Care Act
P.L. 111-152 Health Care and Education Reconciliation Act of 2010
S. 3607 Department of Homeland Security Appropriations Act, 2011 (Drug Importation) S. 3606 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011 (FDA Appropriations, Drug Importation)
S. 3636 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2011 (PTO Provisions, Drug Importation)
S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011(Infectious Disease Provisions)
S. 3397 Secure and Responsible Drug Disposal Act of 2010
H.R. 1359 Secure and Responsible Drug Disposal Act of 2009","Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",60000,,0,0,2010-10-19T17:52:04.760000-04:00
1007464,715a2341-ee97-4f4b-8721-b1a0c6676289,Q3,BUCHANAN INGERSOLL & ROONEY PC,55291,PENNSYLVANIA BIOTECHNOLOGY ASSOCIATION - ALA: PENNSYLVANIA BIO,2010,third_quarter,PHA,"Patent reform, drug importation","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-10-19T18:00:47.690000-04:00
1007681,bdca7db6-75e4-45ea-9d86-0f4876ca9c73,Q3,WINNING STRATEGIES WASHINGTON,50796,MEDA PHARMACEUTICALS,2010,third_quarter,PHA,FDA Risk Evaluation and Mitigation Strategies,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-10-19T18:26:29.353000-04:00
1007692,31b03ed6-ff6d-49c3-8871-ef8e512a4ed1,Q3,WINSTON & STRAWN LLP,41682,FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ),2010,third_quarter,PHA,"Represent the client on issues related to assuring a safe, reliable supply of heparin and also patent matters, including settlements.  Legislation of interest includes the FY 2011 Financial Services Appropriations Bill (S. 3677), the FY 2010 Supplemental Appropriations Bill (H.R. 4899; P.L. 111-212), and the Preserve Access to Affordable Generics Act (S. 369).","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-10-19T18:27:45.003000-04:00
1007746,56276514-8335-4a4e-ae05-ab520eeaddc6,Q3,"PODESTA GROUP, INC.",31680,BRISTOL-MYERS SQUIBB,2010,third_quarter,PHA,"Drug Importation/Drug Safety
P.L. 111-148 Patient Protection and Affordable Care Act
P.L. 111-152 Health Care and Education Reconciliation Act of 2010
S. 3677 Financial Services and General Government Appropriations Act, 2011  (Pay to Delay Provision)","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-10-19T18:37:52.540000-04:00
1008440,35e7ceb6-eb08-475c-89f0-1f0177460f4f,Q3,ANIMAL HEALTH INSTITUTE,4037,ANIMAL HEALTH INSTITUTE,2010,third_quarter,PHA,"Antimicrobial Resistance; HR 1549, S619, Preservation of Antibiotics for Medical Treatment Act; HR2400, Strategies to Address Antimicrobial Resistance Act; S510, Food Safety Modernization Act; HR2749, Food Safety Enhancement Act of 2009; S3307, Healthy Hunger Free Kids Act of 2010; Improving Nutrition for America's Children Act.; Improvement of regulatory review processes for animal health products at FDA Center for Veterinary Medicine and USDA Center for Veternary Biologics","HOUSE OF REPRESENTATIVES,SENATE",,30000,0,0,2010-10-19T21:24:31.597000-04:00
1008656,24408a7c-1f88-4c71-ae14-1816dd0491b4,Q3,MENTAL HEALTH AMERICA,28195,MENTAL HEALTH AMERICA,2010,third_quarter,PHA,Regarding coverage of medications for mental health and substance use disorders in health care reform law (ACA),"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,12514,0,0,2010-10-20T01:28:18.940000-04:00
1008817,eea74c0e-95c4-4351-9d8e-45029aaf30c7,Q3,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF CONNECTICUT,2010,third_quarter,PHA,"S.3606, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA salaries and expenses; and extramural research related issues.","Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA)",40000,,0,0,2010-10-20T05:32:35.327000-04:00
1008820,c0d94e64-7a6f-4af6-b993-e786f2d2b774,Q3,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF MARYLAND BALTIMORE,2010,third_quarter,PHA,No lobbying activity.,"Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-20T05:33:38.247000-04:00
1008833,df76bc18-b26a-4ec8-918a-3aef21505f55,Q3,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE,2010,third_quarter,PHA,"S.3606, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA and USDA funding initiatives; Critical Path Partnership.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2010-10-20T05:34:40.387000-04:00
1009160,00122c03-9297-4f3f-bfdd-e47b8c5bf440,Q3,CHAMBER OF COMMERCE OF THE U.S.A.,38756,CHAMBER OF COMMERCE OF THE U.S.A.,2010,third_quarter,PHA,"H.R. 1346 / S. 540,  Medical Device Safety Act of 2009
H.R. 3590, Patient Protection and Affordable Care Act (P.L. 111-148)","Agriculture, Dept of (USDA),Army, Dept of (Corps of Engineers),Commerce, Dept of (DOC),Commodity Futures Trading Commission (CFTC),Council on Environmental Quality (CEQ),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Environmental Protection Agency (EPA),Equal Employment Opportunity Commission (EEOC),Executive Office of the President (EOP),Export-Import Bank of the United States (EXIM Bank),Federal Communications Commission (FCC),Federal Reserve System,Federal Trade Commission (FTC),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),Justice, Dept of (DOJ),Labor, Dept of (DOL),Maritime Administration (MARAD),Natl Aeronautics & Space Administration (NASA),Natl Economic Council (NEC),Natl Highway Traffic Safety Administration (NHTSA),Natl Institute of Standards & Technology (NIST),Natl Labor Relations Board (NLRB),Natl Security Council (NSC),Office of Management & Budget (OMB),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),State, Dept of (DOS),St. Lawrence Seaway Development Corporation,Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office",,29250000,0,0,2010-10-20T08:02:31.560000-04:00
1009744,60d2fb43-d934-4a74-98a6-36a81555dff5,Q3,EVERTZ GROUP LLC,400497446,MYLAN INC.,2010,third_quarter,PHA,Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program.,"Office of Natl AIDS Policy,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID)",30000,,0,0,2010-10-20T09:41:05.057000-04:00
1010485,75057213-3a74-4564-b9b7-26210b69702a,Q3,"RYAN MACKINNON VASAPOLI AND BERZOK, LLP",30187,NOVO NORDISK,2010,third_quarter,PHA,"H.R. 759, FDA Globalization Act; S. 301, Physician Payments Sunshine Act of 2009; issues related to federal exemption.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-10-20T10:33:33.337000-04:00